Project leads
Collaborators

Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis - NY

Dimitar B Nikolov

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Andrew M Scott

University of Melbourne

Melbourne, Australia

Shahin Rafi

Cornell University

Ithaca, United States

Nayanendu Saha

Memorial Sloan Kettering Cancer Center

New York, United States

Dimitar B Nikolov

Memorial Sloan Kettering Cancer Center

New York, United States

Related projects

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Scott H Kaufmann

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

David Salomon

The Role of Cripto in the Pathogenesis of Breast and Colon Cancer

Alvaro Monteiro

Charting the BRCT Domain Network

Michael Clarke

Self-renewal of Normal and Leukemic Stem Cells

Hodgkin lymphoma Non-Hodgkin lymphoma

Xuebiao Yao

Function of ACAP4 in CCL18-Stimulated Breast Cancer Metastasis

Dihua Yu

Stromal activation in the progression of high ErbB2/1433zeta DCIS to IBC

Charlotte Kuperwasser

Analysis of the cellular and molecular determinants of the human breast hierarchy

Richard G Pestell

Impact of Cyclin D1 Isoforms in Breast Cancer